Nonetheless, it is clear that there is a negative correlation between KLF4 and ESCC progression, while the antitumor role of KLF4 and its molecular mechanisms in early and advanced stages of ESCC need further investigation. The gene discussed is KLF4; the disease is esophageal squamous cell carcinoma.